MedPath

The Effect of Prebiotics on Endurance Performance

Not Applicable
Conditions
Microtia
Interventions
Dietary Supplement: Prebiotic
Other: Placebo
Registration Number
NCT04946578
Lead Sponsor
Maastricht University
Brief Summary

The aim of this study is to investigate the effect of a six-week period personalised food intervention with prebiotic supplementation on intense exercise performance in healthy, recreationally active adults.

Detailed Description

The study conforms to a randomized, single-blinded, placebo-controlled parallel study design.

a prebiotic supplement will be selected based on a participants gut microbiota. 1 sachet of prebiotic or placebo will be given twice a day over a period of 6 weeks.

Before the start of the study, a VO2max test will be performed. Subjects will bring faecal samples which is collected at home. A time to exhaustion of approximately 80% of their VO2max will be performed at baseline and after the 6 weeks intervention period.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Male or female 18 - 40 y
  • BMI range 18.5 - 25 kg/m2
  • Recreational active (performing non-competitive physical endurance exercise at least two times per week with a minimum duration of 60 minutes per exercise bout)
Exclusion Criteria
  • Smoking
  • Performing regular resistance training (3+ times per week, carrying out progressive overload training)
  • Subject following an overly imbalanced or restrictive diet as per nutritional advice
  • Participants who received antibiotics in the 90 days prior to the start of the study
  • Self-admitted lactose intolerance
  • Administration of probiotic or prebiotic supplements in the 14 days prior to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Prebiotic intervention groupPrebioticPrebiotic supplementation
Placebo control groupPlaceboMaltodextrin
Primary Outcome Measures
NameTimeMethod
Time to ExhaustionFrom baseline to end of the study (up to max 45 days)

Time on cycle ergometer until exhaustion

Secondary Outcome Measures
NameTimeMethod
InsulinFrom baseline to end of the study (up to max 45 days)

Fasted insulin

Plasma short chain fatty acidsFrom baseline to end of the study (up to max 45 days)

Short chain fatty acids in plasma

Gut microbiota compositionFrom baseline to end of the study (up to max 45 days)

Composition of the gut microbiota by faecal sample analysis

Blood glucoseFrom baseline to end of the study (up to max 45 days)

Fasted blood glucose

Intestinal permeability by sugar testFrom baseline to end of the study (up to max 45 days)

Intestinal permeability measured by a sugar drink test

Trial Locations

Locations (1)

Maastricht University

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath